Adrenergic blockade in pheochromocytoma.
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D008781:Methyltyrosines / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy*; D011292:Premedication; D011942:Receptors, Adrenergic, alpha / Q000145:classification; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D019805:alpha-Methyltyrosine
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D008781:Methyltyrosines; D011942:Receptors, Adrenergic, alpha; D019805:alpha-Methyltyrosine; D014446:Tyrosine 3-Monooxygenase